Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Intracellular signaling pathways involved in the relaxin-induced proliferation of rat Sertoli cells

Full text
Author(s):
Nascimento, Aline Rosa [1] ; Pimenta, Maristela Taliari [1] ; Lucas, Thais F. G. [1] ; Royer, Carine [1] ; Porto, Catarina Segreti [1] ; Magalhaes Lazari, Maria Fatima [1]
Total Authors: 6
Affiliation:
[1] Univ Fed Sao Paulo, Sect Expt Endocrinol, Dept Pharmacol, Escola Paulista Med, Sao Paulo - Brazil
Total Affiliations: 1
Document type: Journal article
Source: European Journal of Pharmacology; v. 691, n. 1-3, p. 283-291, SEP 15 2012.
Web of Science Citations: 11
Abstract

Regulation of Sertoli cell number is a key event to determine normal spermatogenesis. We have previously shown that relaxin and its G-protein coupled receptor RXFP1 are expressed in rat Sertoli cells, and that relaxin stimulates Sertoli cell proliferation. This study examined the mechanisms underlying the mitogenic effect of relaxin in a primary culture of Sertoli cells removed from testes of immature rats. Stimulation with exogenous relaxin increased Sertoli cell number and the expression of the proliferating cell nuclear antigen (PCNA), but did not affect them RNA level of the differentiation markers cadherins 1 and 2. Relaxin-induced Sertoli cell proliferation was blocked by inhibition of MEK/ERK1/2 or PI3K/AKT pathways, but not by inhibition of PKC or EGFR activity. Relaxin induced a rapid and transient activation of ERK1/2 phosphorylation, which was MEK and SRC-dependent, and involved upstream activation of G(i). AKT activation could be detected 5 min after relaxin stimulation, and was still detected after 24 h of stimulation with relaxin. Relaxin-induced AKT phosphorylation was G(i)- but not PKA-dependent, and it was blocked by both PI3K and MEK inhibitors. In conclusion, the mitogenic effect of relaxin in Sertoli cell involves coupling to G(i) and activation of both MEK/ERK1/2 and PI3K/AKT pathways. (c) 2012 Elsevier B.V. All rights reserved. (AU)